Here’s a roundup of companies announcing new distribution deals.
Qiagen N.V.
Qiagen and Abbott ink viral test deal
Qiagen N.V. (NSDQ:QGEN) and Abbott (NYSE:ABT) entered an agreement that boosts each company’s automated in vitro diagnostic product offerings in the U.S. and Canada.
The supply deal involves the exchange of components for the respective companies’ diagnostic products, designed to make their respective automation platforms and infectious disease testing products more competitive.
Qiagen’s Q4 sales, net earnings rise by double digits
Qiagen N.V. (NSDQ:QGEN) posted fourth-quarter sales of $289.1 million for the three months ended Dec. 31, 2009, up 22 percent compared with $237.2 million during the same period in 2008. Net income rose 32 percent to $57.6 million, compared with $43.7 million during Q4 2008:
Press Release
QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results
Fiscal 2009 Net Sales Exceed $1 Billion